Therapy of histiocytosis X with vincristine, vinblastine, and cyclophosphamide. The Southwest Cancer Chemotherapy Study Group.
D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003345:Corticosterone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007565:Jaundice / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008206:Lymphatic Diseases / Q000188:drug therapy*; D008297:Male; D013431:Sulfates; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use*
D013431:Sulfates; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D003345:Corticosterone